Literature DB >> 11009097

Defective recruitment and activation of ZAP-70 in common variable immunodeficiency patients with T cell defects.

M Boncristiano1, M B Majolini, M M D'Elios, S Pacini, S Valensin, C Ulivieri, A Amedei, B Falini, G Del Prete, J L Telford, C T Baldari.   

Abstract

We have previously identified a subset of common variable immunodeficiency (CVID) patients with defective T cell function associated with impaired activation of the TCR-dependent tyrosine phosphorylation cascade. Here we have assessed the structural and functional integrity of the principal components involved in coupling the TCR/CD3 complex to intracellular tyrosine kinases in two of these patients. We show that ZAP-70 fails to bind the signaling-competent CD3zeta tyrosine phosphorylation isoform and to become activated following TCR engagement, suggesting that defective recruitment of ZAP-70 might underlie the TCR signaling dysfunction in these patients. Determination of the nucleotide sequences encoding the intracellular domains of the CD3/zeta subunits and ZAP-70 did not reveal any mutation. Furthermore, ZAP-70 from these patients could interact in vitro with recombinant phospho-zeta, ruling out genetic defects at the immunoreceptor tyrosine-based activation motif/SH2 domain interface responsible for ZAP-70 recruitment to the activated TCR. No defect was found in expression, activity or subcellular localization of Lck, which is thought to be primarily responsible for CD3zeta phosphorylation. Hence, while the T cell defect in these CVID patients can be pinpointed to the interaction between ZAP-70 and CD3zeta, the integrity in the components of the signaling machinery involved in this process suggests that additional components might be required for completion of this step.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11009097     DOI: 10.1002/1521-4141(200009)30:9<2632::AID-IMMU2632>3.0.CO;2-C

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  16 in total

1.  Defective functions of polymorphonuclear neutrophils in patients with common variable immunodeficiency.

Authors:  Sarah Casulli; Hélène Coignard-Biehler; Karima Amazzough; Michka Shoai-Tehrani; Jagadeesh Bayry; Nizar Mahlaoui; Carole Elbim; Srini V Kaveri
Journal:  Immunol Res       Date:  2014-10       Impact factor: 2.829

2.  B-cell and T-cell phenotypes in CVID patients correlate with the clinical phenotype of the disease.

Authors:  Gaël Mouillot; Maryvonnick Carmagnat; Laurence Gérard; Jean-Luc Garnier; Claire Fieschi; Nicolas Vince; Lionel Karlin; Jean-François Viallard; Roland Jaussaud; Julien Boileau; Jean Donadieu; Martine Gardembas; Nicolas Schleinitz; Felipe Suarez; Eric Hachulla; Karen Delavigne; Martine Morisset; Serge Jacquot; Nicolas Just; Lionel Galicier; Dominique Charron; Patrice Debré; Eric Oksenhendler; Claire Rabian
Journal:  J Clin Immunol       Date:  2010-05-01       Impact factor: 8.317

3.  Deficiency of somatic hypermutation of immunoglobulin G transcripts is a better predictor of severe respiratory tract infections than lack of memory B cells in common variable immunodeficiency.

Authors:  Lone Schejbel; Hanne Marquart; Vagn Andersen; Henrik Permin; Pernille Andersen; Arne Svejgaard; Torben Barington
Journal:  J Clin Immunol       Date:  2005-07       Impact factor: 8.317

4.  Measurement of peripheral B cell subpopulations in common variable immunodeficiency (CVID) using a whole blood method.

Authors:  B L Ferry; J Jones; E A Bateman; N Woodham; K Warnatz; M Schlesier; S A Misbah; H H Peter; H M Chapel
Journal:  Clin Exp Immunol       Date:  2005-06       Impact factor: 4.330

5.  T-cell response to viral antigens in adults and children with common variable immunodeficiency and specific antibody deficiency.

Authors:  L M Haveman; J Scherrenburg; L J Maarschalk-Ellerbroek; P D Hoek; R Schuurman; W de Jager; P M Ellerbroek; B J Prakken; D van Baarle; J M van Montfrans
Journal:  Clin Exp Immunol       Date:  2010-04-09       Impact factor: 4.330

6.  Characterization of Herpesvirus saimiri-transformed T lymphocytes from common variable immunodeficiency patients.

Authors:  J A Cabanillas; R Cambronero; A Pacheco-Castro; M C García-Rodríguez; J M Martín-Fernández; G Fontán; J R Regueiro
Journal:  Clin Exp Immunol       Date:  2002-02       Impact factor: 4.330

7.  Linkage of autosomal dominant common variable immunodeficiency to chromosome 5p and evidence for locus heterogeneity.

Authors:  D U Braig; A A Schäffer; E Glocker; U Salzer; K Warnatz; H H Peter; B Grimbacher
Journal:  Hum Genet       Date:  2003-02-06       Impact factor: 4.132

8.  Impaired up-regulation of CD70 and CD86 in naive (CD27-) B cells from patients with common variable immunodeficiency (CVID).

Authors:  C Groth; R Drager; K Warnatz; G Wolff-Vorbeck; S Schmidt; H Eibel; M Schlesier; H-H Peter
Journal:  Clin Exp Immunol       Date:  2002-07       Impact factor: 4.330

Review 9.  Common variable immunodeficiency: etiological and treatment issues.

Authors:  Sean Deane; Carlo Selmi; Stanley M Naguwa; Suzanne S Teuber; M Eric Gershwin
Journal:  Int Arch Allergy Immunol       Date:  2009-07-01       Impact factor: 2.749

Review 10.  The genetics of hypogammaglobulinemia.

Authors:  Bodo Grimbacher; Alejandro A Schäffer; Hans-Hartmut Peter
Journal:  Curr Allergy Asthma Rep       Date:  2004-09       Impact factor: 4.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.